Conquis Financial’s Eli Lilly LLY Stock Holding History

Conquis Financial’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1	Closed	-$772	–	135
2024 Q4	$772	Buy	+1	New	+$828	﹤0.01%	196

Other funds holding LLY

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Conquis Financial's LLY Position: Q1 2025 in Review

Conquis Financial sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 1 share — an estimated $772 sold.

Conquis Financial first reported a position in LLY in Q4 2024 and held it in 1 quarter. The position peaked at $772 in Q4 2024. 3,920 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

Conquis Financial reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
Conquis Financial sold 1 Eli Lilly share in Q1 2025, an estimated $772.
Conquis Financial first reported a position in Eli Lilly in Q4 2024 and held it in 1 quarter.
Conquis Financial's Eli Lilly position peaked at $772 in Q4 2024.
3,920 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Conquis Financial's 13F filing for Q1 2025, filed 9 May 2025.